- Home /
- Live Rates /
- GH

GH
Last Updated: Jun 24, 2026 03:06:49 PM (GMT)
GH: The current market price is 138.455, reflecting a percentage change of +5.05% from the previous price.
Support and Resistance Levels The pivot point is at 131.8, with three support levels at 131.8 and three resistance levels at 131.8.
Indicators RSI is currently at 60.05, showing a rising trend. ATR is 0.2996 with a history of increasing values. The MACD currently stands at 0.42049, which indicates a bullish crossover. Parabolic SAR is at 128.63708, suggesting an upward trend.
Market Sentiment The price is above the pivot point (131.8), and indicators are supportive of a bullish trend due to rising RSI and MACD crossover.
GH Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (gh) Guardant Health Inc.
Company Background
Guardant Health Inc. (NASDAQ: GH) is a pioneering precision oncology company founded in 2012, headquartered in Redwood City, California. The company focuses on transforming cancer care through its advanced blood-based genomic tests. Guardant's proprietary technology enables the detection of cancer DNA in the bloodstream, facilitating early diagnosis, treatment selection, and monitoring of cancer therapy responses. With a commitment to improving patient outcomes, Guardant Health has positioned itself at the forefront of liquid biopsy innovation, serving both healthcare providers and patients globally.
Market Position
Guardant Health holds a prominent position in the precision oncology market, recognized for its flagship product, Guardant360, a comprehensive liquid biopsy test that profiles genomic alterations in solid tumors. With a growing demand for non-invasive cancer diagnostics and management solutions, Guardant has successfully established partnerships with leading pharmaceutical companies and academic institutions. The company's strong emphasis on research and development further solidifies its market leadership, allowing it to expand its product offerings, including GuardantOMNI and Guardant Reveal, catering to diverse diagnostic needs in oncology.
Key Financial and Industry Highlights
As of October 2023, Guardant Health has demonstrated robust financial performance, with significant revenue growth driven by increasing adoption of its liquid biopsy tests. The company reported a revenue of $147.6 million in 2022, marking a 43% increase from the previous year. This growth trajectory is backed by a growing customer base and expanding market presence, as Guardant continues to penetrate international markets and enhance its product pipeline. Industry trends indicate a rising preference for liquid biopsies among oncologists and patients, driven by their non-invasive nature and the ability to provide real-time insights into tumor dynamics. Guardant Health's innovative solutions position it well to capitalize on these trends, directly impacting its future growth and market expansion.
How to Buy or Trade Guardant Health Inc. Stock (GH) with AvaTrade
Trading or investing in Guardant Health Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol GH, which represents Guardant Health Inc.. Before placing a trade, review the live Guardant Health Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Guardant Health Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Guardant Health Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Indicator Alert
Warning: Several indicator values are missing for this timeframe. Please choose another timeframe to continue.
Sidebar rates
- <% signal.pair %>
<% signal.analyst %>
